Lee, H.; Kim, T.H.; Park, D.; Jang, M.; Chung, J.J.; Kim, S.H.; Kim, S.-H.; Lee, K.H.; Jung, Y.; Oh, S.J.
Combinatorial Inhibition of Cell Surface Receptors Using Dual Aptamer-Functionalized Nanoconstructs for Cancer Treatment. Pharmaceutics 2020, 12, 689.
https://doi.org/10.3390/pharmaceutics12070689
AMA Style
Lee H, Kim TH, Park D, Jang M, Chung JJ, Kim SH, Kim S-H, Lee KH, Jung Y, Oh SJ.
Combinatorial Inhibition of Cell Surface Receptors Using Dual Aptamer-Functionalized Nanoconstructs for Cancer Treatment. Pharmaceutics. 2020; 12(7):689.
https://doi.org/10.3390/pharmaceutics12070689
Chicago/Turabian Style
Lee, Hyojin, Tae Hee Kim, Daechan Park, Mihue Jang, Justin J. Chung, Soo Hyun Kim, Sang-Heon Kim, Kwan Hyi Lee, Youngmee Jung, and Seung Ja Oh.
2020. "Combinatorial Inhibition of Cell Surface Receptors Using Dual Aptamer-Functionalized Nanoconstructs for Cancer Treatment" Pharmaceutics 12, no. 7: 689.
https://doi.org/10.3390/pharmaceutics12070689
APA Style
Lee, H., Kim, T. H., Park, D., Jang, M., Chung, J. J., Kim, S. H., Kim, S.-H., Lee, K. H., Jung, Y., & Oh, S. J.
(2020). Combinatorial Inhibition of Cell Surface Receptors Using Dual Aptamer-Functionalized Nanoconstructs for Cancer Treatment. Pharmaceutics, 12(7), 689.
https://doi.org/10.3390/pharmaceutics12070689